Drug manufacturing and formulation program (dmfp) task order #01: performance activity 1 technical support (1/15/15 1/14/16)

Ended Awarded Last action

Contract number
HHSN27100001
Awardee
Awarding agency
Obligated
$514,881

Award facts

Opportunity
Contract value 100% obligated
$514,881.25 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Kansas City, MO 64110, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 -$778
Funding Only Action P00015 · To administratively DE-obligate unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30,… -$6,829
Funding Only Action P00014 -$278
Exercise an Option P00013 $63,208
Funding Only Action P00012 -$34,892
Exercise an Option P00011 · Drug manufacturing and formulation program $61,480
Funding Only Action P00010 · Midwest research institute -drug manufacturing and formulation -$1,573
Exercise an Option P00009 · Midwest research institute -drug manufacturing and formulation - to 1, exercise option 7 $59,788
Funding Only Action P00008 · Deobligate FY 16 funds -$303
Exercise an Option P00007 · Midwest research institute -drug manufacturing and formulation - to 1, exercise option 6 $58,167
Funding Only Action P00006 -$274
Exercise an Option P00005 $56,580
Exercise an Option P00004 · Midwest research institute $55,038
Exercise an Option 3 $53,536
Exercise an Option 2 $52,073
Exercise an Option 1 $50,656
Original award $49,282
Show all 17

About this award

The National Institute of Neurological Disorders and Stroke issued a delivery order to Mriglobal (doing business as Midwest Research Institute) on January 15, 2015, under the Drug Manufacturing and Formulation Program (DMFP) with a ceiling value of $514,881.25. The order, which was cost-plus-fixed-fee priced and required de-obligation of unexpended fiscal year 2020 funding by September 30, 2025, called for technical support under Performance Activity 1 with an ultimate completion date of January 14, 2025.

Place of performance was Kansas City, Missouri. Service Contract Inventory reporting shows declining labor intensity: FY2024 (the most recent reported year) recorded 0.1 FTEs and 191 contractor hours at a government-paid rate of $337.17 per hour, down from $1,814.59 per hour in FY2022. Mriglobal self-performed all reported work with no subcontractors.

Quick answers

Who was awarded contract HHSN27100001?

HHSN27100001 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on January 15, 2015.

How much is contract HHSN27100001 worth?

The government has obligated $514,881 on HHSN27100001.

Which agency awarded contract HHSN27100001?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Is contract HHSN27100001 an order under another contract?

Yes. HHSN27100001 is a delivery order under HHSN271201500006I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).

Was contract HHSN27100001 competed?

The extent of competition for HHSN27100001 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award